SAPONARO, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 3.419
EU - Europa 2.973
AS - Asia 1.375
SA - Sud America 292
AF - Africa 36
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.101
Nazione #
US - Stati Uniti d'America 3.356
FI - Finlandia 1.929
SG - Singapore 418
CN - Cina 391
DE - Germania 247
BR - Brasile 237
IT - Italia 205
VN - Vietnam 204
PL - Polonia 162
HK - Hong Kong 101
TR - Turchia 101
GB - Regno Unito 86
UA - Ucraina 86
SE - Svezia 63
RU - Federazione Russa 55
FR - Francia 48
IN - India 40
CA - Canada 38
JP - Giappone 22
AR - Argentina 21
BE - Belgio 21
ZA - Sudafrica 21
MX - Messico 19
BD - Bangladesh 18
ID - Indonesia 17
IQ - Iraq 16
ES - Italia 15
NL - Olanda 15
CO - Colombia 10
AT - Austria 9
EC - Ecuador 8
CZ - Repubblica Ceca 7
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
UY - Uruguay 5
AU - Australia 4
CL - Cile 4
KR - Corea 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
PH - Filippine 2
PY - Paraguay 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TT - Trinidad e Tobago 1
Totale 8.101
Città #
Helsinki 1.884
Dallas 746
Ashburn 347
Singapore 282
Fairfield 279
Woodbridge 268
Warsaw 160
Houston 139
Ann Arbor 135
San Jose 134
Beijing 128
Wilmington 117
Chandler 112
Jacksonville 102
Seattle 102
Santa Clara 97
Hong Kong 96
Cambridge 91
Ferrara 86
Munich 67
Los Angeles 49
Ho Chi Minh City 48
Hanoi 47
Izmir 38
New York 37
Shanghai 33
Nanjing 32
Dong Ket 28
Milan 25
Boardman 24
Princeton 24
São Paulo 23
Turku 23
Brussels 21
Lauterbourg 21
Tokyo 20
Orem 18
San Diego 17
Council Bluffs 14
Montreal 12
Shenyang 12
Amsterdam 11
Frankfurt am Main 11
Baghdad 10
Chicago 10
Stockholm 10
Toronto 10
Changsha 9
London 9
Atlanta 8
Brasília 8
Da Nang 8
Hebei 8
Jiaxing 8
Mexico City 8
Mumbai 8
Redwood City 8
Tianjin 8
Addison 7
Ankara 7
Bremen 7
Brooklyn 7
Buffalo 7
Denver 7
Guangzhou 7
Haiphong 7
Johannesburg 7
Mcallen 7
Phoenix 7
Poplar 7
Des Moines 6
Hefei 6
Hải Dương 6
Jakarta 6
Montréal 6
Nanchang 6
Auburn Hills 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Chennai 5
Curitiba 5
Falls Church 5
Montevideo 5
Moscow 5
Querétaro 5
Rome 5
San Mateo 5
Tashkent 5
Thái Nguyên 5
Zhengzhou 5
Bari 4
Boston 4
Cagliari 4
Guarulhos 4
Istanbul 4
Jinan 4
Manchester 4
Mountain View 4
Rio de Janeiro 4
Totale 6.321
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.087
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists 310
A3 adenosine receptor antagonists: History and future perspectives 283
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 280
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 272
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 256
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 245
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 237
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 236
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 223
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 220
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 207
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 201
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 199
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 155
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy 140
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 137
null 124
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 122
null 121
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 120
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 119
null 118
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 115
null 107
null 103
null 96
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 92
null 84
null 83
Transient receptor potential ankyrin 1 (TRPA1) antagonists 64
Totale 8.156
Categoria #
all - tutte 22.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.009
Totale 23.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 51 41 50
2021/2022321 20 17 31 15 28 18 15 15 22 33 23 84
2022/2023286 29 37 4 39 37 40 22 16 37 1 12 12
2023/2024216 17 16 8 5 22 42 6 33 2 6 5 54
2024/2025773 23 42 63 39 72 77 53 47 95 46 109 107
2025/20264.389 211 261 708 256 304 154 208 101 2.016 170 0 0
Totale 8.156